HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
12.20
+0.04 (0.33%)
At close: Aug 14, 2026, 4:00 PM EDT
12.21
+0.01 (0.08%)
After-hours: Aug 14, 2026, 7:34 PM EDT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, HUTCHMED (China) stock has a consensus rating of "Buy" and an average price target of $20.99. The average 1-year stock price forecast is 72.05% higher than the current stock price, while the lowest is $11.1 (-9.02%) and the highest is $40.4 (+231.15%).
Price Target: $20.99 (+72.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HUTCHMED (China) stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 7 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +31.15% | Jul 31, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $16 → $14 | Hold | Reiterates | $16 → $14 | +14.75% | Jul 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Upgrades $14 → $14 | Hold | Upgrades | $14 → $14 | +11.48% | May 28, 2026 |
Financial Forecast
Revenue This Year
607.40M
from 548.51M
Increased by 10.74%
Revenue Next Year
688.94M
from 607.40M
Increased by 13.42%
EPS This Year
0.05
from 0.52
Decreased by -91.27%
EPS Next Year
0.06
from 0.05
Increased by 41.42%
EPS and Forward PE are based on non-GAAP adjusted numbers.